The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 150 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
Vision:
The Centre for Bioengineering & Biotechnology (CBB) enables interdisciplinary research across the university to address global challenges in human health and help translate those research results rapidly into practice, policy and impactful health outcomes. Achieving this vision will help the University of Waterloo to cement an international reputation at the interface of technology and human health.
Mission:
To achieve this vision, CBB's mission is to:
- Enable knowledge translation and support of the interdisciplinary research community through seminars, networking opportunities, and support of student groups
- Be a conduit to Waterloo's ecosystem of unique health related R&D and clinical resources
- Cultivate relationships with key stakeholders in technology, human, animal and environmental health and practice including industry, hospitals, community, and international bodies
- Provide Project Coordination/Management for large/inter-institutional projects
Join us:
To become a member of CBB, you can start by filling out a quick survey. We will then be in touch to discuss further.
News
KA Imaging achieves Health Canada license and FDA clearance for innovative X-ray technology
Digital X-ray technology developed by a University of Waterloo spinoff company has won approval from Health Canada.
A medical device licence issued for Reveal 35C, a dual-energy X-ray detector created by KA Imaging, follows clearance from the Food and Drug Administration in the United States earlier this month.
New diabetes device monitors blood using radar and AI, not painful pricks
CBB members, George Shaker and Safieddin (Ali) Safavi-Naeini part of team that creates new technology that can quickly and accurately monitor glucose levels in people with diabetes without painful finger pricks to draw blood.
New technology can quickly and accurately monitor glucose levels in people with diabetes without painful finger pricks to draw blood.
A palm-sized device developed by researchers at the University of Waterloo uses radar and artificial intelligence (AI) to non-invasively read blood inside the human body.
New Executive Director of CBB Announcement: Congratulations Karim Karim!
